Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: drug costs

12/12/2017

Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’

1 10/21/2016

Are expensive, potent anti-inflammatory drugs a future option for depression? CNN’s story needed more scrutiny of evidence

3/6/2016

False balance in CNN coverage of female sexual dysfunction: anecdotes given equal weight as systematic evidence review

2/26/2016

Interesting but evidence-free story on ibuprofen skin patch

1/7/2016

A gloss over costs in coverage of competing blood pressure meds — but also some strengths

1 11/13/2015

WSJ whiffs on meaningful aspects of new melanoma drug approval — including $17,600/month price tag

2 10/29/2015

Thorough look at underuse of long-term reversible contraceptives

1 9/28/2015

With just 226 words, NYT can’t deliver needed context on Alzheimer’s agitation study

4/22/2015

Story on new melanoma drug combo neglects to mention $250,000 price tag

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
researchmattersSarah Greene@researchmatters·

New article by @UnhealthyAlcDrg & @garyschwitzer is 💯on point. This sums it up perfectly: "The COVID-19 pandemic has created perhaps the most challenging time for science communication in decades." #hcldr
Communicating Science in the Time of a Pandemic https://ja.ma/3ftMYpT

Reply on Twitter 1283088415974584320Retweet on Twitter 12830884159745843205Like on Twitter 12830884159745843204Twitter 1283088415974584320
Retweet on TwitterHealthNewsReview.org Retweeted
CaulfieldTimTimothy Caulfield@CaulfieldTim·

Important piece: "Communicating Science in the Time of a #Pandemic" https://jamanetwork.com/journals/jama/fullarticle/2768397 by @UnhealthyAlcDrg & @garyschwitzer via @JAMA_current

Needed: < hype & > caution

Science & health community: "reflect on how the words and the data matter, & then act accordingly."

Reply on Twitter 1283044794726522883Retweet on Twitter 128304479472652288311Like on Twitter 128304479472652288321Twitter 1283044794726522883
Retweet on TwitterHealthNewsReview.org Retweeted
KariTikkinenKari Tikkinen@KariTikkinen·

All science communicators should read this very useful and smart about 1-page article "Communicating Science in the Time of a Pandemic" published in the JAMA written by Richard Saitz (@UnhealthyAlcDrg) & Gary Schwitzer (@garyschwitzer). @hsfi https://jamanetwork.com/journals/jama/fullarticle/2768397 #EBM #COVID

3
Reply on Twitter 1283005777754705921Retweet on Twitter 128300577775470592118Like on Twitter 128300577775470592141Twitter 1283005777754705921
View More

Categories

View More

Tags